Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. (updated: April 1, 2015)
The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.
No sequence conservation computed yet.
Total structural coverage: 100%
No model available.
(right-click above to access to more options from the contextual menu)
The reference OMIM entry for this protein is 603084
Aspartyl-trna synthetase; dars
Asprs
DESCRIPTION
The DARS gene encodes cytoplasmic aspartyl-tRNA synthetase. Aminoacyl-tRNA synthetases constitute a family of enzymes catalyzing the specific aminoacylation of cognate tRNA in the initial step of ribosome-dependent protein biosynthesis. Mammalian synthetases differ from those of prokaryotes and lower eukaryotes in that they associate as multienzyme complexes (summary by Jacobo-Molina et al., 1989).
CLONING
By screening a HeLa cell cDNA library with a rat Dars cDNA cloned by them, Jacobo-Molina et al. (1989) isolated a cDNA encoding DARS. The predicted DARS protein has 500 amino acids and a calculated molecular mass of 57,000 Da. The human DARS protein has 95% amino acid identity with rat Dars and shares unevenly distributed identity with yeast aspartyl-tRNA synthetase, with 69% identity at the C-terminal half and 46% identity at the N-terminal half. The authors discussed several potential functional domains in the DAR protein, including a region of conserved lysine residues which is also found in bacterial and yeast synthetases and is likely to be the binding site for the 3-prime end of tRNA, a nucleotide triphosphate-binding motif, an ATP-binding motif with strong similarity to that present in E. coli alanyl-tRNA synthetase, and a cyclic AMP-dependent protein kinase phosphorylation site. Jacobo-Molina et al. (1989) predicted a neutral amphiphilic helix at the N-terminal end of the DARS protein and stated that this structure does not occur in other known synthetases from bacteria, yeast, and higher organisms. Based on a curated set of publicly available data, Taft et al. (2013) found that Dars is diffusely localized in the cytoplasm and broadly expressed across tissue types, including the central nervous system. In mice, Dars showed specific expression in neurons of the hippocampus, the dentate gyrus, and the molecular layer of the cerebellum. DARS expression in the developing and adult human brain showed a similar pattern, with preferential immunostaining of neurons in the cerebellum, cerebral cortex, hippocampus, and lateral ventricle. In addition, staining of peripheral neurons was evident in the colon. Lo et al. (2014) reported the discovery of a large number of natural catalytic nulls for each human aminoacyl tRNA synthetase. Splicing events retain noncatalytic domains while ablating the catalytic domain to create catalytic nulls with diverse functions. Each synthetase is converted into several new signaling proteins with biologic activities 'orthogonal' to that of the catalytic parent. The recombinant aminoacyl tRNA synthetase variants had specific biologic activities across a spectrum of cell-based assays: about 46% across all species affect transcriptional regulation, 22% cell differentiation, 10% immunomodulation, 10% cytoprotection, and 4% each for proliferation, adipogenesis/cholesterol transport, and inflammatory response. Lo et al. (2014) identified in-frame splice variants of cytoplasmic aminoacyl tRNA synthetases. They identified 4 catalytic-null and 1 catalytic domain-retained splice variants for AspRS.
MAPPING
Gross (2012) mapped the DARS gene to chromosome 2q21.3 based on an alignment of the DARS sequence (GenBank GENBANK BC
000629) with the genomic sequence (GRCh37).
MOLECULAR GENETICS
In 10 patients from 7 unrelated families of various origins with hypomyelination with brainstem and spinal cord involvement and spasticity (HBSL;
615281), Taft et al. (2013) identif ...
More on the omim web site
Subscribe to this protein entry history
Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated
Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated
Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated
March 16, 2016: Protein entry updated
Automatic update: OMIM entry 603084 was added.
Jan. 27, 2016: Protein entry updated
Automatic update: model status changed
Jan. 24, 2016: Protein entry updated
Automatic update: model status changed